{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acute+Bacterial+Skin+and+Skin+Structure+Infection", "query": { "condition": "Acute Bacterial Skin and Skin Structure Infection" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 46, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acute+Bacterial+Skin+and+Skin+Structure+Infection&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T08:15:33.131Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01400867", "title": "Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Infections, Pediatrics" ], "interventions": [ { "name": "Ceftaroline fosamil", "type": "DRUG" }, { "name": "Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam", "type": "DRUG" }, { "name": "Cephalexin or Clindamycin or Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Months to 17 Years" }, "enrollment_count": 163, "start_date": "2011-12", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2015-01-13", "last_synced_at": "2026-05-22T08:15:33.131Z", "location_count": 28, "location_summary": "Phoenix, Arizona • Orange, California • San Diego, California + 23 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01400867" }, { "nct_id": "NCT01283581", "title": "A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Skin and Subcutaneous Tissue Bacterial Infections" ], "interventions": [ { "name": "Delafloxacin", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" }, { "name": "Vancomycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Melinta Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 256, "start_date": "2011-01", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2019-10-16", "last_synced_at": "2026-05-22T08:15:33.131Z", "location_count": 31, "location_summary": "Mobile, Alabama • Montgomery, Alabama • Buena Park, California + 27 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Buena Park", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01283581" }, { "nct_id": "NCT01209078", "title": "GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Skin Infections, Bacterial" ], "interventions": [ { "name": "GSK1322322", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" }, { "name": "GSK1322322 placebo", "type": "DRUG" }, { "name": "Linezolid placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 84, "start_date": "2010-08-17", "completion_date": "2011-01-18", "has_results": true, "last_update_posted_date": "2017-12-04", "last_synced_at": "2026-05-22T08:15:33.131Z", "location_count": 7, "location_summary": "Anniston, Alabama • Chula Vista, California • La Mesa, California + 4 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01209078" }, { "nct_id": "NCT02426918", "title": "Study of Debio 1450 for Bacterial Skin Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bacterial Infections" ], "interventions": [ { "name": "Debio 1450 IV", "type": "DRUG" }, { "name": "Debio 1450 Oral", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" }, { "name": "Debio 1450 Oral Placebo", "type": "DRUG" }, { "name": "Linezolid Placebo", "type": "DRUG" }, { "name": "Vancomycin IV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Debiopharm International SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 330, "start_date": "2015-05", "completion_date": "2016-09", "has_results": true, "last_update_posted_date": "2019-11-13", "last_synced_at": "2026-05-22T08:15:33.131Z", "location_count": 22, "location_summary": "Anaheim, California • Buena Park, California • Chula Vista, California + 17 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Anaheim", "state": "California" }, { "city": "Buena Park", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02426918" }, { "nct_id": "NCT04806620", "title": "Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Post-Acute COVID-19 Syndrome", "ME/CFS", "Rheumatic Arthritis", "Juvenile Rheumatoid Arthritis (JRA)", "Psoriatic Arthritis (PsA)", "Ankylosing Spondylitis (AS)", "Autoimmune Encephalitis", "Celiac Disease", "Celiac Disease in Children", "Chronic Lyme Disease", "Post-treatment Lyme Disease Syndrome", "Crohn's Disease", "Dysautonomia", "Anorexia Nervosa", "Bulimia Nervosa", "ARFID", "Avoidant / Restrictive Food Intake Disorder", "Ehlers Danlos Syndrome", "Endometriosis", "Fibromyalgia (FM)", "Long COVID", "Lupus", "Migraines", "Mast Cell Activation Syndrome", "Multiple Sclerosis", "Myalgic Encephalomyelitis (ME)", "Myasthenia Gravis, Generalized", "Myasthenia Gravis in Children", "Narcolepsy", "Obsessive Compulsive Disorder (OCD)", "PANDAS", "Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)", "POTS - Postural Orthostatic Tachycardia Syndrome", "General Anxiety Disorder, Social Anxiety Disorder", "PTSD - Post Traumatic Stress Disorder", "Psoriasis", "Traumatic Brain Injury", "Tourette's Syndrome", "Inflammatory Bowel Disease (IBD)", "Autoimmune Diseases", "Neurological Diseases or Conditions", "Psychiatric Disorder", "Sjogren's Syndrome", "Ulcerative Colitis and Crohn's Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Brain Inflammation Collaborative", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 10000, "start_date": "2023-07-05", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-05-22T08:15:33.131Z", "location_count": 1, "location_summary": "Delafield, Wisconsin", "locations": [ { "city": "Delafield", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04806620" }, { "nct_id": "NCT00324324", "title": "Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Breast Cancer", "Chronic Myeloproliferative Disorders", "Gestational Trophoblastic Tumor", "Infection", "Leukemia", "Lymphoma", "Multiple Myeloma and Plasma Cell Neoplasm", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Neoplasms", "Neuroblastoma", "Ovarian Cancer", "Testicular Germ Cell Tumor" ], "interventions": [ { "name": "moxifloxacin hydrochloride", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "OHSU Knight Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 240, "start_date": "2006-05", "completion_date": "2012-12", "has_results": false, "last_update_posted_date": "2017-05-09", "last_synced_at": "2026-05-22T08:15:33.131Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00324324" }, { "nct_id": "NCT01619410", "title": "Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Skin Diseases, Bacterial", "Abscess" ], "interventions": [ { "name": "Linezolid", "type": "BIOLOGICAL" }, { "name": "Clindamycin", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2012-01", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2019-11-08", "last_synced_at": "2026-05-22T08:15:33.131Z", "location_count": 2, "location_summary": "Atlanta, Georgia • Chicago, Illinois", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01619410" }, { "nct_id": "NCT02925416", "title": "Safety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and Skin Structure Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Skin Diseases, Bacterial" ], "interventions": [ { "name": "Oritavancin", "type": "DRUG" }, { "name": "Placebo (D5W)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Medicines Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2017-01-24", "completion_date": "2017-06-20", "has_results": true, "last_update_posted_date": "2024-02-01", "last_synced_at": "2026-05-22T08:15:33.131Z", "location_count": 1, "location_summary": "Somers Point, New Jersey", "locations": [ { "city": "Somers Point", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02925416" }, { "nct_id": "NCT02052388", "title": "Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Skin Infection", "Bacterial Infection" ], "interventions": [ { "name": "Daptomycin", "type": "DRUG" }, { "name": "Brilacidin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cellceutix Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 215, "start_date": "2014-02", "completion_date": "2014-10", "has_results": false, "last_update_posted_date": "2018-09-26", "last_synced_at": "2026-05-22T08:15:33.131Z", "location_count": 4, "location_summary": "Chula Vista, California • La Mesa, California • Oceanside, California + 1 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT02052388" }, { "nct_id": "NCT02066402", "title": "Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bacterial Infections" ], "interventions": [ { "name": "Tedizolid (BAY119-2631)", "type": "DRUG" }, { "name": "Placebo Tedizolid (BAY119-2631)", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" }, { "name": "Placebo Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 598, "start_date": "2014-03-04", "completion_date": "2016-04-18", "has_results": true, "last_update_posted_date": "2017-06-07", "last_synced_at": "2026-05-22T08:15:33.131Z", "location_count": 5, "location_summary": "Chula Vista, California • La Mesa, California • Oceanside, California + 2 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Las Vegas", "state": "Nevada" }, { "city": "Teaneck", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02066402" } ] }